Min, Le

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis

Barroso-Sousa, R., Barry, W. T., Garrido-Castro, A. C., Hodi, F. S., Min, L., Krop, I. E., & Tolaney, S. M. (2018) · JAMA Oncology

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 1,115

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy

Min, L., Vaidya, A., & Becker, C. (2011) · European Journal of Endocrinology

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 179

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Lee, H., Hodi, F. S., Giobbie-Hurder, A., Ott, P. A., Buchbinder, E. I., Haq, R., Tolaney, S., Barroso-Sousa, R., Zhang, K., Donahue, H., et al. (2017) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 161

Ipilimumab-induced autoimmune adrenalitis

Min, L., & Ibrahim, N. (2013) · The Lancet Diabetes & Endocrinology

Adrenal Hormones and DisordersCancer Immunotherapy and Biomarkers

Cited by 112

Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma

Angell, T. E., Min, L., Wieczorek, T. J., & Hodi, F. S. (2018) · Genes & Diseases

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 69

GnRH-Deficient Phenotypes in Humans and Mice with Heterozygous Variants in KISS1/Kiss1

Chan, Y.-M., Broder-Fingert, S., Paraschos, S., Lapatto, R., Au, M., Hughes, V., Bianco, S. D. C., Min, L., Plummer, L., Cerrato, F., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Hypothalamic control of reproductive hormonesSexual Differentiation and Disorders

Cited by 68